Profile
Dr. Henryk Kalisz is Chief Scientific Officer at EUCODIS Bioscience GmbH.
Dr. Kalisz was previously employed as Head-Biochemistry by Pharmacia SpA and a Principal by Helmholtz-Zentrum für Infektionsforschung GmbH.
He received his undergraduate degree from The University of Manchester and a doctorate degree from The University of Manchester.
Former positions of Henryk Kalisz
| Companies | Position | End |
|---|---|---|
| Pharmacia Italia Spa | Corporate Officer/Principal | - |
Helmholtz-Zentrum für Infektionsforschung GmbH
 Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Corporate Officer/Principal | - |
EUCODIS Bioscience GmbH
 EUCODIS Bioscience GmbH Drugstore ChainsRetail Trade EUCODIS Bioscience GmbH provides enzyme solutions. Its applications are used in biopharma, chemicals and cosmetics industries. The company is headquartered in Vienna, Austria. | Chief Tech/Sci/R&D Officer | - |
Training of Henryk Kalisz
| The University of Manchester | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
EUCODIS Bioscience GmbH
EUCODIS Bioscience GmbH Drugstore ChainsRetail Trade EUCODIS Bioscience GmbH provides enzyme solutions. Its applications are used in biopharma, chemicals and cosmetics industries. The company is headquartered in Vienna, Austria. | Retail Trade |
| Pharmacia Italia Spa | |
Helmholtz-Zentrum für Infektionsforschung GmbH
Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Health Technology |
- Stock Market
- Insiders
- Henryk Kalisz
